http://www.zibb.com/all/theme/cq/Derma+Sciences+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Fri, 20 Nov 2009 22:22:21 GMTFri, 20 Nov 2009 22:22:21 GMT608831http://www.zibb.com/all/theme/cq/Derma+Sciences+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.surgistrategies.com/hotnews/fda-issues-guidance-fo-derma-sciences.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+TodaysSurgicenter-BreakingNews+%28SurgiStrategies+-+News%29PRINCETON, NJ--Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a specialty medical device / pharmaceutical company specializing in advanced wound care, announced today that the Food and Drug Administration (FDA)has issued its Guidance Document to support the classification of the Company'shttp://www.surgistrategies.com/hotnews/fda-issues-guidance-fo-derma-sciences.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+TodaysSurgicenter-BreakingNews+%28SurgiStrategies+-+News%29Derma Sciences IncorporatedFri, 20 Nov 2009 22:22:21 GMThttp://www.zibb.com/article/5676585/Derma+Sciences+Inc+DSCI+OB+Corporate+Event+Announcement+NoticeDerma Sciences, Inc. (DSCI.OB) Expected next earnings release: Announcement date: 2/16/2010 - Before Market Earnings Quarter: Q4 Announcement Status: Unconfirmed Expected next investor conference call information: Conference Call Date: 11/16/2009 Conference Call Time (ET): 11:00 AM Conference Callhttp://www.zibb.com/article/5676585/Derma+Sciences+Inc+DSCI+OB+Corporate+Event+Announcement+NoticeDerma Sciences IncorporatedTue, 17 Nov 2009 20:55:51 GMThttp://www.prnewswire.com/news-releases/derma-sciences-reports-third-quarter-2009-results-70177147.htmlDerma Sciences Reports Third Quarter 2009 Results. Significant Quarter-over-Quarter Improvement Enables Company to Achieve Profitability Conference Call Scheduled for 11 am Today.http://www.prnewswire.com/news-releases/derma-sciences-reports-third-quarter-2009-results-70177147.htmlDerma Sciences IncorporatedMon, 16 Nov 2009 12:13:00 GMThttp://finance.yahoo.com/news/FDA-Issues-Guidance-for-Derma-prnews-4053982991.html?x=0&.v=1PRINCETON, N.J., Oct. 28 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI - News), a specialty medical device / pharmaceutical company specializing in advanced woundhttp://finance.yahoo.com/news/FDA-Issues-Guidance-for-Derma-prnews-4053982991.html?x=0&.v=1Derma Sciences IncorporatedWed, 28 Oct 2009 13:29:00 GMThttp://www.biospace.com/news_story.aspx?StoryID=154872&full=1PRINCETON, N.J., Sept. 2 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. , a provider of advanced wound care products, will present at Rodman & Renshaw's Eleventh Annual Healthcare Conference taking place September 9 - 11, 2009, at the New York Palace Hotel. Edward J. Quilty,http://www.biospace.com/news_story.aspx?StoryID=154872&full=1Derma Sciences IncorporatedThu, 03 Sep 2009 12:00:00 GMThttp://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/09-02-2009/0005086969&EDATE=Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, will present at Rodman & Renshaw's Eleventh Annual Healthcare Conference taking place September 9 - 11, 2009, at the New York Palace Hotel. Edward J.http://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/09-02-2009/0005086969&EDATE=Derma Sciences IncorporatedWed, 02 Sep 2009 12:45:00 GMThttp://www.pharmaceutical-business-review.com/article_news.asp?guid=29DF0104-89FD-44AC-A170-06AC69055051Derma Sciences, a provider of advanced wound care products, has signed an agreement with MedEfficiency for the exclusive distribution of the companys novel total contact casts.http://www.pharmaceutical-business-review.com/article_news.asp?guid=29DF0104-89FD-44AC-A170-06AC69055051Derma Sciences IncorporatedThu, 28 Aug 2008 15:21:00 GMThttp://www.pharmacychoice.com/News/article.cfm?Article_ID=319117/PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced today that its first BIOGUARD Barrier Dressings have received clearance from the U.S. Food and Drug Administration for marketing and distribution.http://www.pharmacychoice.com/News/article.cfm?Article_ID=319117Derma Sciences Incorporatedhttp://topics.nytimes.com/top/news/business/companies/derma-sciences-inc/index.htmlScherer Healthcare Inc. and Derma Sciences Inc. dropped their joint hostile takeover bid for the Procyte Corporation yesterday. The two companies said they still planned to explore a possible merger with each other.http://topics.nytimes.com/top/news/business/companies/derma-sciences-inc/index.htmlDerma Sciences Incorporatedhttp://www.zibb.com/article/5673908/Stockguru+com+Derma+Sciences+Inc+is+in+the+StockGuru+Spotlight+for+NovemberDALLAS, TEXAS : StockGuru announces that Derma Sciences Inc. (OTCBB: DSCI) is in the StockGuru Spotlight. Derma Sciences is a specialty medical device / pharmaceutical company focusing on advanced wound care. Its key product, MEDIHONEY , is sold throughout the world by Derma Sciences and Comvitahttp://www.zibb.com/article/5673908/Stockguru+com+Derma+Sciences+Inc+is+in+the+StockGuru+Spotlight+for+NovemberDerma Sciences IncorporatedTue, 17 Nov 2009 05:09:46 GMThttp://www.zibb.com/article/5673121/Derma+Sciences+Inc+DSCI+OB+Corporate+Event+Announcement+NoticeDerma Sciences, Inc. (DSCI.OB) Expected next earnings release: Announcement date: 11/16/2009 - Before Market Earnings Quarter: Q3 Announcement Status: Verified Expected next investor conference call information: Conference Call Date: 11/16/2009 Conference Call Time (ET): 11:00 AM Conference Callhttp://www.zibb.com/article/5673121/Derma+Sciences+Inc+DSCI+OB+Corporate+Event+Announcement+NoticeDerma Sciences IncorporatedMon, 16 Nov 2009 20:50:20 GMThttp://www.prnewswire.com/news-releases/derma-sciences-announces-date-of-its-third-quarter-2009-earnings-release-and-conference-call-69362017.htmlDerma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call.http://www.prnewswire.com/news-releases/derma-sciences-announces-date-of-its-third-quarter-2009-earnings-release-and-conference-call-69362017.htmlDerma Sciences IncorporatedFri, 06 Nov 2009 11:47:00 GMThttp://www.biospace.com/news_story.aspx?StoryID=153395&full=1PRINCETON, N.J., Aug. 17 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. , a provider of advanced wound care products, reports results today for the second quarter and six months ended June 30, 2009.Highlights for second quarter and six months ended June 30,http://www.biospace.com/news_story.aspx?StoryID=153395&full=1Derma Sciences IncorporatedMon, 17 Aug 2009 12:00:00 GMThttp://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/07-20-2009/0005062599&EDATE=Investor Relations Group (IRG), a thirteen-year-old, award-winning corporate communications firm based in New York City, to serve as its national investor relations and public relations firm.http://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/07-20-2009/0005062599&EDATE=Derma Sciences IncorporatedMon, 20 Jul 2009 13:15:00 GMThttp://finance.yahoo.com/news/Derma-Sciences-Announces-prnews-1082060086.html?x=0&.v=1{ "market" : {"NAME" : "U.S.", "ID" : "us_market", "TZ" : "ET", "TZOFFSET" : "-14400", "open" : "1245763807", "close" : "1245787207", "flags" : {}} , "STREAMER_SERVER" : "http://streamerapi.finance.yahoo.http://finance.yahoo.com/news/Derma-Sciences-Announces-prnews-1082060086.html?x=0&.v=1Derma Sciences IncorporatedTue, 23 Jun 2009 13:28:00 GMThttp://www.biospace.com/news_story.aspx?StoryID=139478&full=1PRINCETON, N.J., May 11 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. , a provider of advanced wound care products, announced plans to release its first quarter 2009 results before market on Monday, May 18, 2009. The Company will hold a conference call that same day to discuss the results athttp://www.biospace.com/news_story.aspx?StoryID=139478&full=1Derma Sciences IncorporatedTue, 12 May 2009 12:00:00 GMThttp://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/05-11-2009/0005023591&EDATE=. Interested parties should call 800-299-8538 (domestic) or 617-786-2902 (international), with passcode 98098954 to access the call. You may also access this call via the Internet at:http://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/05-11-2009/0005023591&EDATE=Derma Sciences IncorporatedMon, 11 May 2009 15:56:00 GMThttp://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/10-28-2008/0004913093&EDATE=Immensely popular licensed characters will add significant growth to the company's first aid division PRINCETON, N.J., Oct. 28 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI) announced today that it has secured two additional licenses to manufacture character bandages.http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/10-28-2008/0004913093&EDATE=Derma Sciences IncorporatedTue, 28 Oct 2008 14:48:00 GMThttp://www.zibb.com/article/5650525/StockProfiler+US+Stock+Watch+DSCI+VLYF+PRGFDerma Sciences, Inc. (OTC Bulletin Board: DSCI); Valley Forge Composite Technologies, Inc. (OTC Bulletin Board: VLYF); Proginet Corporation (OTCBB: PRGF) Don't Bother with the Rest, come to the Best! No one covers Stock Market News like we do! StockProfiler.US is the Unquestioned Leader inhttp://www.zibb.com/article/5650525/StockProfiler+US+Stock+Watch+DSCI+VLYF+PRGFDerma Sciences IncorporatedFri, 06 Nov 2009 10:50:39 GMThttp://www.zibb.com/article/5500566/Derma+Sciences+To+Present+at+Rodman+Renshaw+s+Eleventh+Annual+Healthcare+ConferenceDerma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, will present at Rodman & Renshaw's Eleventh Annual Healthcare Conference taking place September 9 - 11, 2009, at the New York Palace Hotel. Edward J. Quilty, Chairman and Chief Executive Officer willhttp://www.zibb.com/article/5500566/Derma+Sciences+To+Present+at+Rodman+Renshaw+s+Eleventh+Annual+Healthcare+ConferenceDerma Sciences IncorporatedWed, 02 Sep 2009 08:45:00 GMThttp://www.zibb.com/article/5495234/Derma+Sciences+OTC+DSCI+Unique+Opportunity+in+Advancing+Wound+CareDerma Sciences (OTC:DSCI) is an intriguing company developing a patented topical drug for accelerated healing and scar prevention and newly launched Advanced Wound Care products approaching $10M, including the highly received MEDIHONEY® dressings at greater than 70% gross margin. Dermahttp://www.zibb.com/article/5495234/Derma+Sciences+OTC+DSCI+Unique+Opportunity+in+Advancing+Wound+CareDerma Sciences IncorporatedMon, 31 Aug 2009 09:42:06 GMThttp://www.biospace.com/news_story.aspx?StoryID=152721&full=1PRINCETON, N.J., Aug. 10 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. , a provider of advanced wound care products, announced plans to release its second quarter 2009 results before market on Monday, August 17, 2009. The Company will hold a conference call that same day to discuss thehttp://www.biospace.com/news_story.aspx?StoryID=152721&full=1Derma Sciences IncorporatedMon, 10 Aug 2009 12:00:00 GMThttp://www.biospace.com/news_story.aspx?StoryID=147295&full=1PRINCETON, N.J., June 23 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. , a provider of advanced wound care products, announced today that it has begun shipping BIOGUARD(TM) Barrier Dressings to customers. Separately, the company announced that it has been awarded reimbursement codes for thehttp://www.biospace.com/news_story.aspx?StoryID=147295&full=1Derma Sciences IncorporatedWed, 24 Jun 2009 12:00:00 GMThttp://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/05-06-2009/0005020621&EDATE=Derma Sciences (OTC Bulletin Board: DSCI), a manufacturer and marketer of advanced wound care products, today announced it has signed a new contract to supply private label adhesive bandages to one of the largest medical supply companies in the U.S.http://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/05-06-2009/0005020621&EDATE=Derma Sciences IncorporatedWed, 06 May 2009 15:24:00 GMThttp://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/05-05-2009/0005019998&EDATE=, CEO of Derma Sciences, noted that, "In October, 2007 Nasdaq acquired the Boston Stock Exchange and immediately terminated the exchange's trading activities. Thus, the delisting is merely a formality and should have no impact whatsoever on the trading of our common stock."http://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/05-05-2009/0005019998&EDATE=Derma Sciences IncorporatedTue, 05 May 2009 21:12:00 GMT